What is ice cream? and how can it prevent earthquakeSASÖDKVANSZ
Nancy C Andrews
11:0012:30 :00
Pause
12:3015:00 :00
Breakdance and waffles
Dr Shinichi Muramatsu
09:0011:30 :00
To DNA or not to DNA
Simon Moroney
11:3012:30 :00
break
12:3015:00 :00
Underberg as a remedy?
Dr Shinichi Muramatsu, Nancy C Andrews
Program
Day 1
Day 2
09:0011:00 :00
What is ice cream? and how can it prevent earthquakeSASÖDKVANSZ
Nancy C Andrews
11:0012:30 :00
Pause
12:3015:00 :00
Breakdance and waffles
Dr Shinichi Muramatsu
09:0011:30 :00
To DNA or not to DNA
Simon Moroney
11:3012:30 :00
break
12:3015:00 :00
Underberg as a remedy?
Dr Shinichi Muramatsu
,
Nancy C Andrews
Speaker Profile
Nancy CAndrews
Board member since 2015
Biography
Nancy C. Andrews has extensive experience as a physician, scientist, professor and senior administrator at leading academic institutions and hospitals. Her distinguished career spans more than 30 years, with leadership roles at both Harvard Medical School and the Duke University School of Medicine. Since 2023, Dr. Andrews is professor in residence of pediatrics at Harvard Medical School and is credited with conducting research that led to advances in understanding iron biology and iron diseases.
Speaker Profile
DrShinichiMuramatsu
Specially Appointed Professor
Jichi Medical University, Open Innovation Center, Neurogene Therapy
Biography
NA
Speaker Profile
SimonMoroney
Board member since 2020 | Vice-Chair since March 4, 2022
Biography
As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master’s degree in chemistry.
Speaker Profile
DrShinichiMuramatsu
Specially Appointed Professor
Jichi Medical University, Open Innovation Center, Neurogene Therapy
Biography
NA
Speaker Profile
Nancy CAndrews
Board member since 2015
Biography
Nancy C. Andrews has extensive experience as a physician, scientist, professor and senior administrator at leading academic institutions and hospitals. Her distinguished career spans more than 30 years, with leadership roles at both Harvard Medical School and the Duke University School of Medicine. Since 2023, Dr. Andrews is professor in residence of pediatrics at Harvard Medical School and is credited with conducting research that led to advances in understanding iron biology and iron diseases.
Speaker Profile
Nancy CAndrews
Board member since 2015
Biography
Nancy C. Andrews has extensive experience as a physician, scientist, professor and senior administrator at leading academic institutions and hospitals. Her distinguished career spans more than 30 years, with leadership roles at both Harvard Medical School and the Duke University School of Medicine. Since 2023, Dr. Andrews is professor in residence of pediatrics at Harvard Medical School and is credited with conducting research that led to advances in understanding iron biology and iron diseases.
Speaker Profile
DrShinichiMuramatsu
Specially Appointed Professor
Jichi Medical University, Open Innovation Center, Neurogene Therapy
Biography
NA
Speaker Profile
SimonMoroney
Board member since 2020 | Vice-Chair since March 4, 2022
Biography
As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master’s degree in chemistry.
Speaker Profile
DrShinichiMuramatsu
Specially Appointed Professor
Jichi Medical University, Open Innovation Center, Neurogene Therapy
Biography
NA
Speaker Profile
Nancy CAndrews
Board member since 2015
Biography
Nancy C. Andrews has extensive experience as a physician, scientist, professor and senior administrator at leading academic institutions and hospitals. Her distinguished career spans more than 30 years, with leadership roles at both Harvard Medical School and the Duke University School of Medicine. Since 2023, Dr. Andrews is professor in residence of pediatrics at Harvard Medical School and is credited with conducting research that led to advances in understanding iron biology and iron diseases.
Föreläsare
Simon
Moroney
Board member since 2020 | Vice-Chair since March 4, 2022
Nancy C
Andrews
Board member since 2015
dr
Shinichi
Muramatsu
Specially Appointed Professor
,
Jichi Medical University, Open Innovation Center, Neurogene Therapy
Speaker Profile
SimonMoroney
Board member since 2020 | Vice-Chair since March 4, 2022
Biography
As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master’s degree in chemistry.
Speaker Profile
Nancy CAndrews
Board member since 2015
Biography
Nancy C. Andrews has extensive experience as a physician, scientist, professor and senior administrator at leading academic institutions and hospitals. Her distinguished career spans more than 30 years, with leadership roles at both Harvard Medical School and the Duke University School of Medicine. Since 2023, Dr. Andrews is professor in residence of pediatrics at Harvard Medical School and is credited with conducting research that led to advances in understanding iron biology and iron diseases.
Speaker Profile
DrShinichiMuramatsu
Specially Appointed Professor
Jichi Medical University, Open Innovation Center, Neurogene Therapy
Välkommen till Novartis PRO! Denna webbsida är endast avsedd för personal inom hälso- och sjukvården.
Novartis Pro är Novartis tjänsteportal för dig som arbetar inom vården. Vänligen bekräfta att du arbetar inom hälso- och sjukvården genom att klicka "Fortsätt". Om du inte tillhör denna grupp, vänligen klicka "Avbryt" för att gå till vår webbsida för allmänheten.